Helixgate https://validator.w3.org/feed/docs/rss2.html Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests STAT+: Top health officials highlight efforts to make medical records more portable BBB Access Route via Proteomic Vascular Mapping New rules for CDC vaccine panel aim to address lawsuit, empower Kennedy’s allies Invivyd reveals plans to test an antibody drug against measles FDA plans another safety study of abortion drug after court order AbbVie suggests new interpretation of ‘patient’ is necessary in 340B lawsuit Cancer Drug Shortfalls Tied to How BET Inhibitors Hit BRD2 and BRD4 Differently Organ-on-Chip Integrated Into Preclinical Glioblastoma Research Labguru Customer Portal Launched for CRO/CDMO and Client Collaboration Chasing a tough-to-treat lung disease, Avalyn plans an IPO STAT+: A new health care blueprint from a key Democratic think tank FDA lifts MacroGenics hold; Oxford and Bristol Myers team up Everyone has a mental health chatbot. Now what? STAT+: FDA rejects an industry proposal to deregulate some AI devices China-based AI biotech Ailux hires CSO, eyes clinic in 2027 Avalyn plots IPO to push inhaled pulmonary fibrosis pipeline through clinic STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more Innovent’s CDMO gets green light to make biologics at large Chinese plant Team approach to lowering high blood pressure worked even in ‘a tough landscape’ Opinion: What public health can learn from the MAHA movement STAT+: Influential Democratic think tank pushes plan for government to lower health care costs Neuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling Roche sticks with C4T, adding up to $1B for molecular glue partnership Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors Your DNA has a secret “second code” that decides which genes get silenced STAT+: Which U.S. metros have the highest health spending? The answer might surprise you Pulmonary fibrosis biotech Avalyn Pharma files for IPO Single-Cell Atlas of Maternal–Fetal Interface Sheds Light on Pregnancy Complications Esophagus engineering tackles function Sidewinder secures $137M to advance ‘precision’ ADCs Research uncovers previously unknown recessive condition  PhRMA head Steve Ubl to step down, according to sources With 3 quick buyouts, Gilead leans into its latest transformation Forecasting Protein Aggregation with an Improved Algorithm Activist investor revives campaign to overhaul Novavax board Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application Automation, Collaboration and the Future of Advanced Therapies STAT+: Terns’ drug may not be as competitive as many initially thought Gilead takes another big swing at expanding beyond HIV AC Immune and Lilly reach agreement on drug collaboration  Gilead Less M&A Happy Now but Door Still Open for ‘Compelling’ Opportunities Inside the Talkspace-Universal Health Services deal STAT+: Biotech VCs, used to a winning formula in drug development, face disruption Childhood Dementia Explained by Synaptic Dysfunction, Opens New Therapies 10 Companies Hiring in Texas Now Opinion: Tastiness is not why people overeat STAT+: Pharmalittle: We’re reading about FDA seeking new powers over DTC ads, an EU pledge to fight AMR, and more In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient Home